- ICH GCP
- Registr klinických studií v USA
- Klinická studie NCT06476678
Nový bipolární radiofrekvenční ablační nůž v lézích jícnu
Prospektivní multicentrická studie hodnotící účinnost a proveditelnost nového bipolárního radiofrekvenčního ablačního nože při endoskopické submukózní disekci jícnu
Both Baylor St Luke's Medical Center and Mayo Scottsdale are considered endoscopic submucosal dissection (ESD) centers of excellence. The investigators at Baylor College of Medicine have previously reported our Esophageal ESD experience using the monopolar current knife. Moreover, the research team have previously reported on the clinical efficacy of the bipolar RFA knife during per-oral endoscopic myotomy (POEM) and colonic ESD. The goal of our study is to prospectively evaluate the efficacy, safety and feasibility of Esophageal ESD using a novel Bipolar-Current ESD device.
Přehled studie
Postavení
Intervence / Léčba
Detailní popis
Endoscopic submucosal dissection (ESD) is a novel technique for the removal of esophageal lesions or polyps with high-risk features. ESD is minimally invasive and allows the removal of esophageal polyps without resorting to morbid surgery. The process of ESD includes marking the lesions selected for removal, followed by submucosal injection of a lifting agent, then circumferential incisions using a specialized knife followed by submucosal dissection of the entire lesion.
Traditionally, knifes utilizing monopolar current were the preferred tools for endoscopic submucosal dissection. These knifes allow accurate dissection and excellent hemostasis. However, due to monopolar current generated heat, post coagulation syndrome can be seen in up to 8 to 40 % of patients. Post coagulation syndrome present with pain, fever and leukocytosis and requires supportive treatment with IV fluid and antibiotics. In addition, for large esophageal lesions, stricturing can occur after resection due to significant scar formation resulting from the tissue healing response to electrocautery. Almost all patients with >60% of the esophageal circumference removed via monopolar knives, will develop an esophageal stricture at some point. These patients require serial esophageal dilations, and although easily managed, its development can be quite troublesome to the patient. Nevertheless, ESD is still the preferred modality for removal of these lesions since it avoids the need for morbid surgery.
Recently, a novel Bipolar RFA knife was FDA approved for endoscopic submucosal dissection. The low voltage bipolar system allows for precise cutting of submucosa and muscle using substantially less energy, thereby limiting inadvertent remote thermal effects. Additionally, it allows aggressive coagulation of vessels without dissipation of large amounts of energy, thereby allowing more targeted therapy. Moreover, with the addition of an integrated injection needle, the knife now allows injection, safe cutting and coagulation in one device, potentially supporting more efficient dissection. Ultimately, due to less thermal effect on surrounding tissue, the bipolar knife may allow for removal of large esophageal lesions without causing major esophageal stricturing.
Typ studie
Zápis (Odhadovaný)
Kontakty a umístění
Studijní kontakt
- Jméno: Salmaan A Jawaid, MD
- Telefonní číslo: 7137980950
- E-mail: Salmaan.Jawaid@bcm.edu
Studijní záloha kontaktů
- Jméno: Haydee Rochits Cueto
- Telefonní číslo: 7137983606
- E-mail: Haydee.RochitsCueto@bcm.edu
Studijní místa
-
-
Texas
-
Houston, Texas, Spojené státy, 77030
- Nábor
- Baylor College of Medicine
-
Vrchní vyšetřovatel:
- Salmaan Jawaid, MD
-
Dílčí vyšetřovatel:
- Mohamed Othman, MD
-
Kontakt:
- Salmaan Jawaid, MD
- Telefonní číslo: 713-798-0950
- E-mail: Salmaan.Jawaid@bcm.edu
-
Dílčí vyšetřovatel:
- Tara Keihanian, MD
-
Kontakt:
- Haydee Rochits Cueto
- Telefonní číslo: 7137983606
- E-mail: Haydee.RochitsCueto@bcm.edu
-
-
Kritéria účasti
Kritéria způsobilosti
Věk způsobilý ke studiu
Přijímá zdravé dobrovolníky
Pohlaví způsobilá ke studiu
Metoda odběru vzorků
Studijní populace
All patients undergoing intended ESD of precancerous lesions will be screened by study coordinators for preliminary eligibility and those who meet the inclusion criteria will be approach individually for further discussion about the study and obtaining informed consent.
Popis
Inclusion Criteria:
-
Patient is >18 years of age
-
Patient can provide informed consent
-
Patient is referred for resection of precancerous lesions meeting the following criteria:
- Mucosal based polyp
- Located gastroesophageal junction (GEJ) or proximal to GEJ
- No previous endoscopic resection attempted (EMR or ESD)
Exclusion Criteria:
- Patients with International Normalized Ratio (INR) >1.5 or Platelets <50,000
- Lesions extending past GEJ
- Subepithelial lesions
Studijní plán
Jak je studie koncipována?
Detaily designu
- Observační modely: CASE_ONLY
- Časové perspektivy: PROSPECTIVE
Kohorty a intervence
Skupina / kohorta |
Intervence / Léčba |
|---|---|
|
Treatment arm
Patients who were deemed eligible and signed the consent will undergo the removal of their esophageal precancerous lesion utilizing the novel bipolar knife during their endoscopic submucosal dissection (ESD). |
Use of Speedboat™ Ultraslim for performing endoscopic submucosal dissection of esophageal lesions. |
Co je měření studie?
Primární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Technical success
Časové okno: Day 1 (procedure day)
|
Defined as the ability to perform the entire dissection (procedure) with the novel bipolar knife |
Day 1 (procedure day)
|
Sekundární výstupní opatření
Měření výsledku |
Popis opatření |
Časové okno |
|---|---|---|
|
Speed of Endoscopic Submucosal Dissection
Časové okno: During Procedure
|
The speed of endoscopic submucosal dissection as calculated by cm^2/hour |
During Procedure
|
|
Number of instruments used
Časové okno: During Procedure
|
Logging the variable equipment utilized during the procedure |
During Procedure
|
|
Rate of muscle injury score
Časové okno: During Procedure
|
As calculated by the Sydney Classification of Deep Mural Injury ranging from Type 0 - Type V with Type V as the most severe score. |
During Procedure
|
|
Rate of post-electrocautery syndrome
Časové okno: 24 hours, 2 weeks, and 4 weeks
|
Define as post-procedure abdominal pain, fevers, leukocytosis |
24 hours, 2 weeks, and 4 weeks
|
|
Change in post-procedural pain score
Časové okno: 24 hours, 2 weeks, and 4 weeks
|
As calculated by the visual analog pain scale to measure patient pain ranging from 0-10 with 10 being the most pain. |
24 hours, 2 weeks, and 4 weeks
|
|
Rate of esophageal stricturing
Časové okno: Assessed at any follow-up post-procedure endoscopies up to 6 months
|
Calculated by number of documented occurrences post-procedure for subjects |
Assessed at any follow-up post-procedure endoscopies up to 6 months
|
|
Degree of scar formation
Časové okno: Assessed at any follow-up post-procedure endoscopies up to 6 months
|
Scar formation that occurs in response to electrocautery |
Assessed at any follow-up post-procedure endoscopies up to 6 months
|
|
Cost of dissection
Časové okno: During Procedure
|
As calculated upon review of devices used during dissection procedure |
During Procedure
|
Spolupracovníci a vyšetřovatelé
Sponzor
Spolupracovníci
Termíny studijních záznamů
Hlavní termíny studia
Začátek studia (Aktuální)
Primární dokončení (Odhadovaný)
Dokončení studie (Odhadovaný)
Termíny zápisu do studia
První předloženo
První předloženo, které splnilo kritéria kontroly kvality
První zveřejněno (Aktuální)
Aktualizace studijních záznamů
Poslední zveřejněná aktualizace (Aktuální)
Odeslaná poslední aktualizace, která splnila kritéria kontroly kvality
Naposledy ověřeno
Více informací
Termíny související s touto studií
Další relevantní podmínky MeSH
Další identifikační čísla studie
- H-55206
Informace o lécích a zařízeních, studijní dokumenty
Studuje lékový produkt regulovaný americkým FDA
Studuje produkt zařízení regulovaný americkým úřadem FDA
produkt vyrobený a vyvážený z USA
Tyto informace byly beze změn načteny přímo z webu clinicaltrials.gov. Máte-li jakékoli požadavky na změnu, odstranění nebo aktualizaci podrobností studie, kontaktujte prosím register@clinicaltrials.gov. Jakmile bude změna implementována na clinicaltrials.gov, bude automaticky aktualizována i na našem webu .